Limited-stage SCLC may be considered an early stage of lung cancer. Because this type of cancer grows so quickly, chemotherapy or radiation are considered the best treatments for stopping their growth ...

Tumor staging was reconfirmed according to the 8th Edition of the American Joint Committee on Cancer (AJCC) TNM Classification for Lung Cancer (18). Clinical features and disease progression were ...

The Global Lung Cancer Therapeutics Market is valued at USD 32.5 Billion in 2024 and is projected to reach a value of USD 78.9 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of 8.3% between ...

Low-dose computed tomography is more sensitive than chest radiography in diagnosing lung metastases of second primary lung cancer in HNSCC survivors.

MORGANTOWN, W.Va. — Lung cancer is the leading cause of cancer deaths worldwide, according to the American Cancer Society, ...

While precision oncology requires robust biomarkers, current predictors for lung adenocarcinoma (LUAD) often show limited clinical utility. This study investigates the multifaceted roles of ZC3H12D, a ...

Raymond Osarogiagbon, MD, discusses the challenges of implementing lung cancer screening guidelines and the need for increased awareness and access. In this clip, Raymond Osarogiagbon, MD ...

The test processes whole-slide images of non-small cell lung cancer tissue to provide a quantitative TROP2 score, which Roche says provides a level of precision beyond manual methods. TROP2 has ...

Earlier this year, Mellencamp said doctors discovered several tumors in her brain and lung, which she confirmed were metastases of melanoma and would be treated with surgery and immunotherapy.

"Optune Lua is an innovative and urgently needed new approach for treating metastatic non-small cell lung cancer," said Joachim Aerts, M.D., a LUNAR investigator and Professor of Pulmonary ...